An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)

NCT04987242 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia
Gout
Chronic Kidney Diseases

Interventions

DRUG: ALLN-346
DRUG: Placebo

Sponsor

Allena Pharmaceuticals